Clinical Trials Directory

Trials / Unknown

UnknownNCT04775030

Methodology for Developing an Occlusal Appliance With CBD Active Carrier

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Medical University of Silesia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients

Detailed description

Occlusal appliance therapies are used in TMD patients. In this research the active CBD molecules will be released from the occlusal appliance during nighttime, in population of patients suffering from TMD. The effectiveness of the myorelaxation (sEMG of mastcatory muscles activity) and analgesic effect( VAS analysis) of occlusal appliance with the CBD molecules will be compared to the traditional acrylic-resin material used so far for occlusal appliance manufacture. The aim of the research is the evaluation of the innovative material effectiveness, used for the production of the occlusal appliance.

Conditions

Interventions

TypeNameDescription
DRUGCBD occlusal applianceOcclusal appliance manufactured with CBD molecules released from material to patients oral cavity during sleep time
DEVICEAcrylic resin occlusal applianceAcrylic resin occlusal appliance during sleep time

Timeline

Start date
2021-01-01
Primary completion
2022-01-01
Completion
2023-01-01
First posted
2021-03-01
Last updated
2021-03-01

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04775030. Inclusion in this directory is not an endorsement.